Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.9647
-0.0353 (-3.53%)
Feb 26, 2026, 2:57 PM EST - Market open
Genenta Science Employees
Genenta Science had 13 employees as of December 31, 2024. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
-$785,995
Market Cap
22.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 13 | -1 | -7.14% |
| Dec 31, 2023 | 14 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Barinthus Biotherapeutics | 105 |
| IO Biotech | 78 |
| IGC Pharma | 70 |
| Senti Biosciences | 34 |
| Daré Bioscience | 23 |
| Hyperion DeFi | 14 |
| Exicure | 8 |
| Neuphoria Therapeutics | 8 |
GNTA News
- 4 weeks ago - Micro-Cap Genenta Stock Reacts To Its Big Pivot From Biotech To Defense Investments - Benzinga
- 4 weeks ago - Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator - GlobeNewsWire
- 2 months ago - Genenta Science Provides Update on CEO Ownership - GlobeNewsWire
- 3 months ago - Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial - GlobeNewsWire
- 4 months ago - Genenta: Lentiviral Vector Technology Early Survival GBM Signal Warrants Buy Rating - Seeking Alpha
- 4 months ago - Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares - GlobeNewsWire
- 4 months ago - Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production - GlobeNewsWire
- 8 months ago - Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals - GlobeNewsWire